FIELD: biotechnology.
SUBSTANCE: genetic construct of pMitoCas9 with SEQ ID NO:1 based on the CRISPR/Cas9 genome editing system is obtained, which encodes the cas9 nuclease, specifically imported into human mitochondria.
EFFECT: invention provides efficient synthesis of modified Cas9 nuclease in human cells.
2 dwg
Authors
Dates
2017-10-26—Published
2015-12-01—Filed